Salvianolic acid B attenuates MMP-2 and MMP-9 expression in vivo in apolipoprotein-E-deficient mouse aorta and in vitro in LPS-treated human aortic smooth muscle cells

Journal of Cellular Biochemistry

Volumn 100, Issue 2, 2007, Pages 372-384

  Lin, Shing Jong ^a,b   Lee, I Ta ^a   Chen, Yung Hsiang ^a   Lin, Feng Yen ^a   Sheu, Li Min ^a   Ku, Hung Hai ^a   Shiao, Ming Shi ^b   Chen, Jaw Wen ^a,b   Chen, Yuh Lien ^c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

apo E deficient mice; Matrix metalloproteinase (MMP); Mitogen activated protein kinases (MAPKs); Salvianolic acid B; Smooth muscle cells

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN E; CHOLESTEROL; ENDOTOXIN; GELATINASE A; GELATINASE B; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SALVIANOLIC ACID B; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA MEDIA; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CELL STIMULATION; CHINESE MEDICINE; CHOLESTEROL DIET; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HERB; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTIMA; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RESTENOSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR DISEASE; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; AORTA; APOLIPOPROTEINS E; BENZOFURANS; CELL MOVEMENT; CELLS, CULTURED; CHOLESTEROL; CYCLOOXYGENASE 2; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

MUS;

EID: 33846443173     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21042     Document Type: Article

References (36)

1. Arai K, Lee SR, Lo EH. 2003. Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes. Glia 43:254-264.
2. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. 1994. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 3:539-545.
3. Carrell TW, Burnand KG, Wells GM, Clements JM, Smith A. 2002. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 105:477-482.
4. Chen YH, Lin SJ, Ku HH, Shiao MS, Lin FY, Chen JW, Chen YL. 2001a. Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. J Cell Biochem 82:512-521.
5. Chen YL, Yang SP, Shiao MS, Chen JW, Lin SJ. 2001b. Salvia miltiorrhiza inhibits intimai hyperplasia and monocyte chemotactic protein-1 expression after balloon injury in cholesterol-fed rabbits. J Cell Biochem 83:484-493.
6. Chen YH, Lin SJ, Chen JW, Ku HH, Chen YL. 2002. Magnolol attenuates VCAM-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. Br J Pharmacol 135:37-47.
7. Chen YL, Hu CS, Lin FY, Chen YH, Sheu LM, Ku HH, Shiao MS, Chen JW, Lin SJ. 2006. Salvianolic Acid B attenuates cyclooxygenase-2 expression in vitro in LPS-treated human aortic smooth muscle cells and in vivo in the Apolipoprotein-E-Deficient Mouse Aorta. J Cell Biochem 98:618-631.
8. Cho A, Graves J, Reidy MA. 2000. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 12:2527-2532.
9. Cho A, Reidy MA. 2002. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle replication and migration after arterial injury. Circ Res 91:845-851.
10. Futaki N, Arai I, Hamasaka Y, Takahashi S, Higuchi S, Otomo S. 1993. Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation. J Pharm Pharmacol 45:753-755.
11. Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM, Ivan E. 2002. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 9:852-859.
12. George SJ, Zaltsman AB, Newby AC. 1997. Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein. Cardiovasc Res 33:447-459.
13. Guha M, Mackman N. 2001. LPS induction of gene expression in human monocytes. Cell Signal 13:85-94.
14. Kenagy RD, Hart CE, Stetler-Stevenson WG, Clowes AW. 1997. Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. Circulation 96:3555-3560.
15. Khan KM, Falcone DJ, Kraemer R. 2002. Nerve growth factor activation of Erk-1 and Erk-2 induces matrix metalloproteinase-9 expression in vascular smooth muscle cells. J Biol Chem 277:2353-2359.
16. Lay IS, Hsieh CC, Chiu JH, Shiao MS, Lui WY, Wu CW. 2003. Salvianolic acid B enhances in vitro angiogenesis and improves skin flap survival in sprague-dawley rats. J Surg Res 115:279-285.
17. Lei XL, Chiou GC. 1986. Studies on cardiovascular actions of salvia miltiorrhiza. Am J Chinese Med 14:26-32.
18. Lin TJ, Zhang KJ, Liu GT. 1996. Effects of salvianolic acid A on oxygen radicals released by rat neutrophils and on neutrophil function. Biochem Pharmacol 51:1237-1241.
19. Liu GT, Zhang TM, Wang BE, Wang YW. 1992. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochem Pharmacol 43:147-152.
20. Luttun A, Lutgens E, Manderveld A, Maris K, Collen D, Carmeliet P, Moons L. 2004. Loss of matrix metalloproteinase-9 or matrix metaUoproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation 11:1408-1414.
21. Marcet-Palacios M, Graham K, Cass C, Befus AD, Mayers I, Radomski MW. 2003. Nitric oxide and cyclic GMP increase the expression of matrix metalloproteinase-9 in vascular smooth muscle. J Pharmacol Exp Ther 307:429-436.
22. Moon SK, Cha BY, Kim CH. 2004. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway. J Cell Physiol 3:417-427.
23. Morris GE, Whyte MK, Martin GF, Jose PJ, Dower SK, Sabroe I. 2005. Agonists of toll-like receptors 2 and 4 activate airway smooth muscle via mononuclear leukocytes. Am J Respir Crit Care Med 8:814-822.
24. Nagata T, Kai H, Shibata R, Koga M, Yoshimura A, Imaizumi T, Oncostatin M. 2003. An interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells. Arterioscler Thromb Vasc Biol 4:588-593.
25. Newby AC, Zaltsman AB. 2000. Molecular mechanisms in intimai hyperplasia. J Pathol 190:300-309.
26. Niiro H, Otsuka T, Ogami E, Yamaoka K, Nagano S, Akahoshi M, Nakashima H, Arinobu Y, Izuhara K, Niho Y. 1998. MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes. Biochem Biophys Res Commun 250:200-205.
27. Pasterkamp G, Schoneveld AH, Hijnen DJ, de Kleijn DP, Teepen H, van der Wal AC, Borst C. 2000. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 150:245-253.
28. Recalde D, Ostos MA, Badell E, Garcia-Otin AL, Pidoux J, Castro G, Zakin MM, Scott-Algara D. 2004. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide. Arterioscler Thromb Vasc Biol 24:756-761.
29. Ross R. 1993. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 6423:801-809.
30. Sharony R, Pintucci G, Saunders PC, Grossi EA, Baumann FG, Galloway AC, Mignatti P. 2006. Matrix metalloproteinase expression in vein grafts: Role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2. Am J Physiol Heart Circ Physiol 290:H1651-H1659.
31. Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M. 1998. Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives. J Med Chem 41:640-649.
32. Tang MK, Ren DC, Zhang JT, Du GH. 2002. Effect of salvianolic acids from radix salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine 5:405-409.
33. Uzui H, Lee JD, Shimizu H, Tsutani H, Ueda T. 2000. The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells. Atherosclerosis 149:51-59.
34. Wu YJ, Hong CY, Lin SJ, Wu P, Shiao MS. 1998. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of salvia miltiorrhiza. Arterioscler Thromb Vasc Biol 18:481-486.
35. Zeng B, Prasan A, Fung KC, Solanki V, Bruce D, Freedman SB, Brieger D. 2005. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease. Intern Med J 35:331-353.
36. Zhou XM, Lu ZY, Wang DW. 1996. Experimental study of salvia miltiorrhiza on prevention of restenosis after angioplasty. Zhongguo Zhong Xi Yi Jie He Za Zhi 16:480-482.